Topic starter
17/01/2026 2:48 pm
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow. A team of researchers from Genomill Health Inc., the University of Turku, and the TYKS Turku University Hospital, Finland, benchmarked this new method, Bridge Capture, against two market-leading tools.
https://medicalxpress.com/news/2026-01-liquid-biopsy-technology-lowers-barriers.html